tiprankstipranks
Bioventix PLC (GB:BVXP)
LSE:BVXP

Bioventix (BVXP) Income Statement

4 Followers

Bioventix Income Statement

Last quarter (Q2 2023), Bioventix's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, Bioventix's net income was £―. See Bioventix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
-£ 12.82M£ 11.72M£ 10.93M£ 10.31M£ 9.29M
Cost of Revenue
-£ 828.41K£ 710.45K£ 817.45K£ 821.82K£ 875.09K
Gross Profit
-£ 11.99M£ 11.01M£ 10.11M£ 9.49M£ 8.41M
Operating Expense
-£ 1.92M£ 1.83M£ 1.73M£ 1.51M£ 1.38M
Operating Income
-£ 10.07M£ 9.18M£ 8.38M£ 7.98M£ 7.03M
Net Non Operating Interest Income Expense
-£ 101.09K£ 4.50K£ -30.63K£ 41.07K£ 34.63K
Other Income Expense
------
Pretax Income
-£ 10.13M£ 9.28M£ 8.12M£ 8.23M£ 6.97M
Tax Provision
-£ 1.76M£ 1.60M£ 1.39M£ 1.02M£ 1.10M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ 8.37M£ 7.67M£ 6.73M£ 7.20M£ 5.86M
Basic EPS
-£ 1.61£ 1.47£ 1.29£ 1.39£ 1.14
Diluted EPS
-£ 1.61£ 1.45£ 1.28£ 1.38£ 1.12
Basic Average Shares
-£ 5.21M£ 10.47M£ 5.21M£ 5.17M£ 5.14M
Diluted Average Shares
-£ 5.21M-£ 5.26M£ 5.22M£ 5.23M
Dividend Per Share
-£ 1.62£ 1.26£ 0.95£ 0.79£ 0.66
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-£ 2.75M£ 2.54M£ -2.55M£ 2.33M£ 2.26M
Net Income From Continuing And Discontinued Operation
-£ 8.37M£ 7.67M£ 6.73M£ 7.20M£ 5.86M
Normalized Income
-£ 8.21M£ 7.52M£ 6.58M£ 7.20M£ 5.86M
Interest Expense
-----£ 0.00
EBIT
-£ 10.13M£ 9.28M£ 8.12M£ 7.98M£ 7.03M
EBITDA
-£ 10.26M£ 9.42M£ 8.12M£ 8.11M£ 7.10M
Currency in GBP

Bioventix Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis